Should We Repair Moderate Tricuspid Regurgitation? An Expert Opinion.

IF 2.6 3区医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS

Seminars in Thoracic and Cardiovascular Surgery Pub Date : 2025-02-12 DOI:10.1053/j.semtcvs.2025.01.006

Ricky Patil, Matthew Kazaleh, Gorav Ailawadi

引用次数: 0

Abstract

Lack of consensus on the treatment of tricuspid regurgitation (TR) has limited operative management for decades. However, emerging evidence indicates that intervening on moderate tricuspid regurgitation during concomitant cardiac surgery can be beneficial with appropriate patient selection. Furthermore, advances in transcatheter therapies have changed the landscape of managing tricuspid disease.

查看原文本刊更多论文

求助全文

约1分钟内获得全文求助全文

来源期刊

Seminars in Thoracic and Cardiovascular Surgery Medicine-Pulmonary and Respiratory Medicine

CiteScore

5.80

自引率

0.00%

发文量

324

审稿时长

12 days

期刊介绍： Seminars in Thoracic and Cardiovascular Surgery is devoted to providing a forum for cardiothoracic surgeons to disseminate and discuss important new information and to gain insight into unresolved areas of question in the specialty. Each issue presents readers with a selection of original peer-reviewed articles accompanied by editorial commentary from specialists in the field. In addition, readers are offered valuable invited articles: State of Views editorials and Current Readings highlighting the latest contributions on central or controversial issues. Another prized feature is expert roundtable discussions in which experts debate critical questions for cardiothoracic treatment and care. Seminars is an invitation-only publication that receives original submissions transferred ONLY from its sister publication, The Journal of Thoracic and Cardiovascular Surgery. As we continue to expand the reach of the Journal, we will explore the possibility of accepting unsolicited manuscripts in the future.